Guignat L - Search Results

1

Guignat L, Assie G, Bertagna X, Bertherat J. Guignat L, et al. Presse Med. 2009 Jan;38(1):125-32. doi: 10.1016/j.lpm.2008.10.008. Epub 2008 Nov 28. Presse Med. 2009. PMID: 19041214 French.

2

Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.

Bellanné-Chantelot C, Lévy DJ, Carette C, Saint-Martin C, Riveline JP, Larger E, Valéro R, Gautier JF, Reznik Y, Sola A, Hartemann A, Laboureau-Soares S, Laloi-Michelin M, Lecomte P, Chaillous L, Dubois-Laforgue D, Timsit J; French Monogenic Diabetes Study Group. Bellanné-Chantelot C, et al. J Clin Endocrinol Metab. 2011 Aug;96(8):E1346-51. doi: 10.1210/jc.2011-0268. Epub 2011 Jun 15. J Clin Endocrinol Metab. 2011. PMID: 21677039 Free article.

3

Trabecular bone score (TBS) in Cushing's disease: TBS gain after hypercortisolism normalization.

Tan E, Guignat L, Dellal A, Winzenrieth R, Cormier C, Koumakis E. Tan E, et al. Among authors: guignat l. Bone. 2024 Jul;184:117109. doi: 10.1016/j.bone.2024.117109. Epub 2024 Apr 21. Bone. 2024. PMID: 38643895

4

Leukemia inhibitory factor as an intrapituitary regulator of pro-opiomelanocortin gene expression and corticotrope ontogeny.

Guignat L, Bertherat J. Guignat L, et al. Eur J Endocrinol. 1999 Sep;141(3):214-5. doi: 10.1530/eje.0.1410214. Eur J Endocrinol. 1999. PMID: 10474116 Review. No abstract available.

5

Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.

Mynard V, Guignat L, Devin-Leclerc J, Bertagna X, Catelli MG. Mynard V, et al. Among authors: guignat l. Endocrinology. 2002 Oct;143(10):3916-24. doi: 10.1210/en.2002-220323. Endocrinology. 2002. PMID: 12239103

6

Video-assisted thoracoscopic surgery as a first-line treatment for mediastinal parathyroid adenomas: strategic value of imaging.

Amar L, Guignat L, Tissier F, Richard B, Vignaux O, Fulla Y, Legmann P, Bertagna X, Bonnichon P. Amar L, et al. Among authors: guignat l. Eur J Endocrinol. 2004 Feb;150(2):141-7. doi: 10.1530/eje.0.1500141. Eur J Endocrinol. 2004. PMID: 14763911

7

Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.

Mynard V, Latchoumanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barré B, Fagart J, Coqueret O, Catelli MG. Mynard V, et al. Among authors: guignat l. Mol Endocrinol. 2004 Dec;18(12):2997-3010. doi: 10.1210/me.2003-0417. Epub 2004 Aug 19. Mol Endocrinol. 2004. PMID: 15319449

8

Collision/composite tumors of the adrenal gland: a pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis.

Thorin-Savouré A, Tissier-Rible F, Guignat L, Pellerin A, Bertagna X, Bertherat J, Lefebvre H. Thorin-Savouré A, et al. Among authors: guignat l. J Clin Endocrinol Metab. 2005 Aug;90(8):4924-9. doi: 10.1210/jc.2004-2572. Epub 2005 May 24. J Clin Endocrinol Metab. 2005. PMID: 15914530

9

Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis.

Uzan L, Guignat L, Meune C, Mouly S, Weber S, Bertagna X, Bertherat J, Thomopoulos P, Duboc D. Uzan L, et al. Among authors: guignat l. Drug Saf. 2006;29(3):231-6. doi: 10.2165/00002018-200629030-00006. Drug Saf. 2006. PMID: 16524322

10

[Cushing's syndrome].

Guignat L, Bertagna X, Bertherat J. Guignat L, et al. Rev Prat. 2008 May 15;58(9):957-65. Rev Prat. 2008. PMID: 18672661 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters